minervaneurosciences.com (NERV) - Narxning prognoz qilingan daromadga nisbati
Minerva Neurosciences (NERV) shizofreniyaga qarshi kurashish uchun roluperidone kichik molekulalarini ishlab chiqishga investitsiya kiritmoqda. GURU.Markets grafigidagi oldindan bashorat qilingan sotuvlar nisbati ushbu ishlanmalarni uyqusizlikni davolash vositalarining kelajakdagi sotuvlari bilan bog'laydi, bunda eng so'nggi baholash metrikasini belgilaydi. Shu bilan birga, kompaniya tibbiy chiqindilarni utilizatsiya qilish bo'yicha ekologik qoidalarga qat'iy rioya qilmoqda.
Minerva (NERV) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- kompaniyaning jami qarzi va likvidligi ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Minerva Neurosciences|NERV - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences|NERV - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Minerva|NERV - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzlari Minerva Neurosciences|Tezkor likvidlik koeffitsiyenti minervaneurosciences.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
NERV - Sof moliyaviy natija|Prognoz qilingan kelajakdagi foyda Minerva Neurosciences|NERV - Kapitalizatsiyaning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Minerva Neurosciences Corp|NERV - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|EV/EBITDA multiplikatori Minerva|NERV - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Minerva Neurosciences|NERV - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi minervaneurosciences.com|NERV - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Minerva Neurosciences
- tushum va sotuvlar tafsilotlari:
Kompaniyaning dastlabki tahlili:NERV (Minerva Neurosciences, Inc.)
Minerva Neurosciences neyrobiologiya sohasidagi chuqur tajribasiga tayangan holda, shizofreniya terapiyasi uchun innovatsion dori vositalarini ishlab chiqishga e'tibor qaratadi. Kelgusidagi P/S koeffitsiyenti baholashini tahlil qilish orqali, investor joriy bozor kapitalizatsiyasining prognoz qilingan daromadga nisbatini real vaqt rejimida baholashi mumkin, bu esa salbiy ssenariylar ostida kapitalning xavfsiz boshpanasini aniqlash va kutilayotgan savdo hajmiga nisbatan biznesning diskontlanish darajasini baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Biogen - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx NBIX|RGC - Narxning prognoz qilingan daromadga nisbati|AXSM (Axsome Corp) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ACAD: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati xenon-pharma.com (XENE)|Forvard narx/daromad multiplikatori VKTX|Forvard P/S multiplikatori Supernus Pharmaceuticals, Inc.|Narxning prognoz qilingan daromadga nisbati Catalyst Pharmaceuticals Inc (CPRX)|DNLI (Denali Corp) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Harmony Biosciences HRMY|biohavenpharma.com (BHVN) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|AMLX - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Trevi Therapeutics Inc TRVI|PRAX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Anavex Life Sciences Corp|CBLL (CeriBell, Inc.) - Forvard P/S multiplikatori|Prothena Corporation (PRTA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ALEC|ANNX - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Omeros OMER|NGNE: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|AC Immune - Forvard P/S multiplikatori|voyagertherapeutics.com (VYGR) - Forvard narx/daromad multiplikatori|NMRA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Scilex Holding (SCLX)|Narxning prognoz qilingan daromadga nisbati Tevogen Bio Holdings, Inc.|Alpha Cognition Corp (ACOG) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Cognition Therapeutics (CGTX)|inhibikase.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori SAVA (Cassava Sciences)|Assertio Holdings (ASRT) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|COYA - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx VTGN (Vistagen Therapeutics)|OVID (ovidrx.com) - Forvard narx/daromad multiplikatori|ABOS (acumenpharm.com) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati CervoMed|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATHE (Alterity Therapeutics Ltd)|Forvard P/S multiplikatori CLNN|PEPG - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Jupiter Neurosciences Inc - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori relmada.com RLMD|ANVS - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx GRCE (Grace Therapeutics, Inc.)|Firefly Neuroscience Inc (AIFF) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Klotho Neurosciences (KLTO)|Narxning prognoz qilingan daromadga nisbati NeuroSense Therapeutics Ltd|Forvard narx/daromad multiplikatori revivapharma.com (RVPH)|Forvard P/S multiplikatori MTVA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati NeurAxis Inc.|Narxning prognoz qilingan daromadga nisbati Helius Medical Technologies HSDT|PASG: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Neuphoria - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati athira.com|Addex Therapeutics Ltd (ADXN) - Narxning prognoz qilingan daromadga nisbati|Alzamend Neuro - Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori CYCN|Narxning prognoz qilingan daromadga nisbati PTIX|Forvard P/S multiplikatori KTTA|Forvard P/S multiplikatori cortigent.com (CRGT)|Avenue Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx BCLI|CARA - Narxning prognoz qilingan daromadga nisbati|CHRO (Chromocell) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ELYM: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Intra-Cellular Therapies, Inc. (ITCI)|Forvard narx/daromad multiplikatori LBPH|Forvard P/S multiplikatori Marinus Pharmaceuticals Inc|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|NRBO (NeuroBo Pharma) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Sage Therapeutics, Inc. SAGE|synaptogen.com (SNPX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|TRVN - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Vigil Neuroscience VIGL|WENA: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cerevel Corp
